Bad Pharma

Produktbeschreibung

Paperback. Pub Date :2013-08-29 Pages: 448 Language: English Ben Goldacre puts the 600bn global pharmaceutical industry under the microscope What he reveals is a fascinating. terrifying mess *** Now updated with the latest government responses to the.. bookDoctors and patients need good scientific evidence to make informed decisions. But instead. companies run bad trials on their own drugs. which distort and exaggerate the benefits by design. When these trials produce unflattering results. the data is simply buried. All of this is perfectly legal. In fact. even government regulators withhold vitally important data from the people who need it most. Doctors and patient groups have stood by too. and failed to protect us. Instead. they take money and favours. in a world so fractured that medics and nurses are now educated by the drugs industry.The result: patients are harmed in ... 

Kritik

'This is a book to make you enraged - properly, bone-shakingly furious - because it's about how big business puts profits over patient welfare, allows people to die because they don't want to disclose damning research evidence, and the tricks they play to make sure doctors do not have all the evidence when it comes to appraising whether a drug really works or not. A work of brilliance.' Max Pemberton, Daily Telegraph

'This is a brilliant piece of work' Evening Standard, William Leith

'This is an important book. Ben Goldacre is angry, and by the time you put 'Bad Pharma' down, you should be too.' New Statesman

'Nailing the compromise between too much detail and too little, Goldacre's brilliantly enraging study unpeels how the pharmaceutical giants routinely misrepresent science in their quest for profit.' Sunday Telegraph

'What keeps you turning its pages is the accessibility of Goldacre's writing ... his genuine, indignant passion, his careful gathering of evidence and his use of stories, some of them personal, which bring the book to life.' Luisia Dilner, Guardian

'This is a book that deserves to be widely read, because anyone who does read it cannot help feeling both uncomfortable and angry.' Economist

''Bad Pharma' will confirm his status as a thorn in the side of the medical Establishment - Goldacre's detailed research would be hard for any drug-company executive to contradict' Lois Rogers, Sunday Times 

Autoreninfo

Ben Goldacre